Dr. Kenechukwu Olufemi Chudy-Onwugaje
MBBS, MPH, MS, FACG
Specialty
Gastroenterology, Interventional Endoscopy
Bio
Dr. Kenechukwu Olufemi Chudy-Onwugaje is a Gastroenterologist and Interventional Endoscopist who is certified by the American Board of Internal Medicine in Internal Medicine and Gastroenterology and Hepatology. He completed his training in Advanced Endoscopy at the University of Pennsylvania in Philadelphia, and is currently as Associate Scholar at the Center for Global Health at the University of Pennsylvania.
Dr. Chudy-Onwugaje is a Fellow of the American College of Gastroenterology and currently serves as Chair of the International Relations Committee of the College. He is also a member of the American Society for Gastrointestinal Endoscopy and the American Gastroenterological Association.
- Fellowship in Advanced Endoscopy: University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA
- Fellowship in Gastroenterology and Hepatology: University of Maryland Medical Center, Baltimore, Maryland, USA
- Chief Resident in Internal Medicine: Maimonides Medical Center, Brooklyn, New York, USA
- Residency in Internal Medicine: Maimonides Medical Center, Brooklyn, New York, USA
- Medical School: Nnamdi Azikiwe University, Awka.
- Master of Public Health (MPH): Simon Fraser University, Burnaby, British Columbia, Canada
- Master of Science in Clinical Research (MS): University of Maryland, Baltimore, Maryland, USA.
- Diplomate, American Board of Internal Medicine
- Diplomate, American Board of Internal Medicine, Subspecialty Gastroenterology and Hepatology
- Fellow, American College of Gastroenterology
Chudy-Onwugaje KO, Christian KE, Farraye FA, Cross RK.: A State-of-the-art review of new and emerging therapies for the treatment of IBD. Inflamm Bowel Dis. 25(5):820 – 830, 2019
Chudy-Onwugaje K, von Rosenvinge E. Improving global digestive health: the gastroenterologists’ role. Lancet Gastroenterol Hepatol. 2020;5(10):882 – 883. PMID 32941831.
Chudy-Onwugaje KO, Huang W, Su JL, Purdue MP, Johnson CC, Wang L, Katki HA, Barry KH, Berndt SI. Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial. Cancer. 2021;127(17):3145 – 3155. PMID 33974712
Chudy-Onwugaje KO, Mamunes AP, Schwartz DA, Horst S, Cross RK. Predictors of high health care utilization in patients with inflammatory bowel disease within 1 year of establishing specialist care. Inflamm Bowel Dis. 2021;27(3):325-335. PMID 32488231.
Thiruvengadam NR, Kouanda A, Kalluri A, Schaubel D, Saumoy M, Forde K, Song J, Faggen A, Davis BG, Chudy-Onwugaje KO, Cote G, Arain MA, Kochman ML. A Prospective Cohort Study evaluating PAN-PROMISE, a patient-reported outcome measure to detect post-ERCP morbidity. Clin Gastroenterol Hepatol. 2023;21(5):1233 – 1242. PMID 36075501.
Copyright © 2025 Redus All Rights Reserved.